Page 3 - Vercise Genus News Today

Jan 25, 2021 7:30am The fourth generation of Boston Scientifics Vercise Genus system was approved for the stimulation of areas of the brain linked to the control of behavior and movement for patients with Parkinson’s disease who have responded to levodopa treatment, but whose symptoms are not adequately controlled with medication alone. (Boston Scientific) Boston Scientific has obtained approval from the FDA for the fourth generation of its Vercise Genus deep brain stimulation system,...

Medtronic said the ADAPT-PD study will look at the safety and efficacy of the use of adaptive deep brain stimulation in patients with Parkinson’s Disease.